Total Funding
10
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
Bruce Markham: President & CEO, Chief Scientific Officer & Co-FounderPast Role: Phrixus Pharmaceuticals, CSO, VO R&D,V,Co-Founder
James Symons: V-P Clinical DeveloppmentPast Role: Meditrina Pharmaceuticals, VP, Clinical Development
About the Company
Phrixus Pharmaceuticals, Inc. develops and commercializes pharmaceuticval s and therapies related to heart failure. The company develops Carmeseal, a therapy for the treatment of heart failure. Phrixus Pharmaceuticals, Inc. was incorporated in 2006 and is based in Ann Arbor, Michigan.
